A 2-year prospective densitometric study on the influence of Fok-I gene polymorphism in young patients with thalassaemia major

Osteoporosis International

Volumn 27, Issue 2, 2016, Pages 781-788

  Dimitriadou, M ^a   Christoforidis, A ^a   Fidani, L ^a   Economou, M ^a   Vlachaki, E ^b   Athanassiou Metaxa, M ^a   Katzos, G ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b Ippokration Hospital Thessaloniki   (Greece)

Author keywords

Dual energy X ray absorptiometry; Fok I gene polymorphism; Thalassaemia; Vitamin D; Vitamin D receptor

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; FOK 1 PROTEIN; PARATHYROID HORMONE; PROTEIN; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR;

ADOLESCENT; ADULT; AGE; ALLELE; ARTICLE; BONE DENSITOMETRY; BONE MASS; CAUCASIAN; CHILD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MOLECULAR EVOLUTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX; THALASSEMIA MAJOR; YOUNG ADULT; ANTHROPOMETRY; BETA THALASSEMIA; BONE DENSITY; FEMORAL NECK; GENETICS; HIP; LUMBAR VERTEBRA; PATHOPHYSIOLOGY; PHOTON ABSORPTIOMETRY; PROCEDURES; SINGLE NUCLEOTIDE POLYMORPHISM;

ABSORPTIOMETRY, PHOTON; ADOLESCENT; ADULT; ANTHROPOMETRY; BETA-THALASSEMIA; BONE DENSITY; CHILD; FEMALE; FEMUR NECK; HIP JOINT; HUMANS; LUMBAR VERTEBRAE; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RECEPTORS, CALCITRIOL; YOUNG ADULT;

EID: 84957429632     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-015-3264-1     Document Type: Article

References (43)

1. Ladis V, Karagiorga-Lagana M, Tsatra I, Chouliaras G (2013) Thirty-year experience in preventing haemoglobinopathies in Greece: achievements and potentials for optimisation. Eur J Haematol 90(4):313–322. doi:10.1111/ejh.12076
2. Skordis N, Toumba M (2011) Bone disease in thalassaemia major: recent advances in pathogenesis and clinical aspects. Pediatr Endocrinol Rev 8(Suppl 2):300–306
3. Haidar R, Musallam KM, Taher AT (2011) Bone disease and skeletal complications in patients with beta thalassemia major. Bone 48(3):425–432. doi:10.1016/j.bone.2010.10.173
4. Voskaridou E, Terpos E (2008) Pathogenesis and management of osteoporosis in thalassemia. Pediatr Endocrinol Rev 6(Suppl 1):86–93
5. Bikle DD (2014) Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol 21(3):319–329. doi:10.1016/j.chembiol.2013.12.016
6. Lucotte G, Mercier G, Burckel A (1999) Fok I polymorphism at the human vitamin D receptor gene locus in Europeans and Africans. Clin Genet 55(4):281–282
7. Kalkwarf HJ, Zemel BS, Gilsanz V, Lappe JM, Horlick M, Oberfield S, Mahboubi S, Fan B, Frederick MM, Winer K, Shepherd JA (2007) The bone mineral density in childhood study: bone mineral content and density according to age, sex, and race. J Clin Endocrinol Metab 92(6):2087–2099. doi:10.1210/jc.2006-2553
8. Chiotis DT G, Hatzisymeon M, Maniati-Christidi M, Dacou-Voutetakis D (2003) Height and weight of children of Hellenic origin aged 0–18 years (2000–2001): comparison with data collected during the period 1978–1979. Ann Clin Pediatr Univ Atheniensis 50(2):136–155
9. Chiotis DK,X, Tsiftis G, Hatzisymeon M, Maniati-Christidi M, Dacou-Voutetaki A (2004) Body mass index and prevalence of obesity in subjects of Hellenic origin aged 0–18 years, living in the Athens area. Ann Clin Pediatr Unive Atheniensis 51(2):139–154
10. Mayo O (2008) A century of Hardy-Weinberg equilibrium. Twin Res Hum Genet 11(3):249–256. doi:10.1375/twin.11.3.249
11. Vogiatzi MG, Autio KA, Mait JE, Schneider R, Lesser M, Giardina PJ (2005) Low bone mineral density in adolescents with beta-thalassemia. Ann N Y Acad Sci 1054:462–466. doi:10.1196/annals.1345.063
12. Jensen CE, Tuck SM, Agnew JE, Koneru S, Morris RW, Yardumian A, Prescott E, Hoffbrand AV, Wonke B (1998) High incidence of osteoporosis in thalassaemia major. J Pediatr Endocrinol Metab 11(Suppl 3):975–977
13. Ferrara M, Matarese SM, Francese M, Borrelli B, Coppola A, Coppola L, Esposito L (2002) Effect of VDR polymorphisms on growth and bone mineral density in homozygous beta thalassaemia. Br J Haematol 117(2):436–440. doi:10.1046/j.1365-2141.2002.03426.x
14. Singh K, Kumar R, Shukla A, Phadke SR, Agarwal S (2012) Status of 25-hydroxyvitamin D deficiency and effect of vitamin D receptor gene polymorphisms on bone mineral density in thalassemia patients of North India. Hematology 17(5):291–296. doi:10.1179/1607845412Y.0000000017
15. Tantawy AA, El Kholy M, Moustafa T, Elsedfy HH (2008) Bone mineral density and calcium metabolism in adolescents with beta-thalassemia major. Pediatr Endocrinol Rev 6(Suppl 1):132–135
16. Tantawy AA, El-Bostany EA, Matter RM, El-Ghoroury EA, Ragab S (2010) Predictors of bone disease in Egyptian prepubertal children with beta-thalassaemia major. Arch Med Sci 6(4):584–591. doi:10.5114/aoms.2010.14472
17. Gaudio A, Morabito N, Xourafa A, Curro M, Caccamo D, Ferlazzo N, Macri I, La Rosa MA, Meo A, Ientile R (2010) Role of genetic pattern on bone mineral density in thalassemic patients. Clin Biochem 43(10–11):805–807. doi:10.1016/j.clinbiochem.2010.04.070
18. Jakubowska-Pietkiewicz E, Mlynarski W, Klich I, Fendler W, Chlebna-Sokol D (2012) Vitamin D receptor gene variability as a factor influencing bone mineral density in pediatric patients. Mol Biol Rep 39(5):6243–6250. doi:10.1007/s11033-012-1444-z
19. Terpstra L, Knol DL, Van Coeverden SC, Delemarre-van de Waal HA (2006) Bone metabolism markers predict increase in bone mass, height and sitting height during puberty depending on the VDR Fok1 genotype. Clin Endocrinol (Oxf) 64(6):625–631. doi:10.1111/j.1365-2265.2006.02516.x
20. Kanan RM (2013) The effect of FokI vitamin D receptor polymorphism on bone mineral density in Jordanian perimenopausal women. Indian J Hum Genet 19(2):233–238. doi:10.4103/0971-6866.116125
21. Falchetti A, Sferrazza C, Cepollaro C, Gozzini A, Del Monte F, Masi L, Napoli N, Di Fede G, Cannone V, Cusumano G, Pandolfo MC, Rini GB, Tanini A, Brandi ML (2007) FokI polymorphism of the vitamin D receptor gene correlates with parameters of bone mass and turnover in a female population of the Italian island of Lampedusa. Calcif Tissue Int 80(1):15–20. doi:10.1007/s00223-005-0295-1
22. Kanan RM, Varanasi SS, Francis RM, Parker L, Datta HK (2000) Vitamin D receptor gene start codon polymorphism (FokI) and bone mineral density in healthy male subjects. Clin Endocrinol (Oxf) 53(1):93–98. doi:10.1046/j.1365-2265.2000.01059.x
23. Strandberg S, Nordstrom P, Lorentzon R, Lorentzon M (2003) Vitamin D receptor start codon polymorphism (FokI) is related to bone mineral density in healthy adolescent boys. J Bone Miner Metab 21(2):109–113. doi:10.1007/s007740300018
24. Zajickova K, Zofkova I, Bahbouh R, Krepelova A (2002) Vitamin D receptor gene polymorphisms, bone mineral density and bone turnover: FokI genotype is related to postmenopausal bone mass. Physiol Res 51(5):501–509
25. Ames SK, Ellis KJ, Gunn SK, Copeland KC, Abrams SA (1999) Vitamin D receptor gene Fok1 polymorphism predicts calcium absorption and bone mineral density in children. J Bone Miner Res 14(5):740–746. doi:10.1359/jbmr.1999.14.5.740
26. Abrams SA, Griffin IJ, Hawthorne KM, Chen Z, Gunn SK, Wilde M, Darlington G, Shypailo RJ, Ellis KJ (2005) Vitamin D receptor Fok1 polymorphisms affect calcium absorption, kinetics, and bone mineralization rates during puberty. J Bone Miner Res 20(6):945–953. doi:10.1359/JBMR.050114
27. Arai H, Miyamoto K, Taketani Y, Yamamoto H, Iemori Y, Morita K, Tonai T, Nishisho T, Mori S, Takeda E (1997) A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res 12(6):915–921. doi:10.1359/jbmr.1997.12.6.915
28. Gross C, Krishnan AV, Malloy PJ, Eccleshall TR, Zhao XY, Feldman D (1998) The vitamin D receptor gene start codon polymorphism: a functional analysis of FokI variants. J Bone Miner Res 13(11):1691–1699. doi:10.1359/jbmr.1998.13.11.1691
29. Tzoulis P, Ang AL, Shah FT, Berovic M, Prescott E, Jones R, Barnard M (2014) Prevalence of low bone mass and vitamin D deficiency in beta-thalassemia major. Hemoglobin 38(3):173–178. doi:10.3109/03630269.2014.905792
30. Christoforidis A, Kazantzidou E, Tsatra I, Tsantali H, Koliakos G, Hatzipantelis E, Katzos G, Athanassiou-Metaxa M (2007) Normal lumbar bone mineral density in optimally treated children and young adolescents with beta-thalassaemia major. Hormones (Athens) 6(4):334–340
31. Wong P, Fuller PJ, Gillespie MT, Kartsogiannis V, Kerr PG, Doery JC, Paul E, Bowden DK, Strauss BJ, Milat F (2014) Thalassemia bone disease: a 19-year longitudinal analysis. J Bone Miner Res 29(11):2468–2473. doi:10.1002/jbmr.2266
32. Lasco A, Morabito N, Gaudio A, Crisafulli A, Meo A, Denuzzo G, Frisina N (2002) Osteoporosis and beta-thalassemia major: role of the IGF-I/IGFBP-III axis. J Endocrinol Invest 25(4):338–344. doi:10.1007/BF03344015
33. Pirinccioglu AG, Akpolat V, Koksal O, Haspolat K, Soker M (2011) Bone mineral density in children with beta-thalassemia major in Diyarbakir. Bone 49(4):819–823. doi:10.1016/j.bone.2011.07.014
34. Baldini M, Forti S, Marcon A, Ulivieri FM, Orsatti A, Tampieri B, Airaghi L, Zanaboni L, Cappellini MD (2010) Endocrine and bone disease in appropriately treated adult patients with beta-thalassemia major. Ann Hematol 89(12):1207–1213. doi:10.1007/s00277-010-1007-0
35. Dresner Pollack R, Rachmilewitz E, Blumenfeld A, Idelson M, Goldfarb AW (2000) Bone mineral metabolism in adults with beta-thalassaemia major and intermedia. Br J Haematol 111(3):902–907. doi:10.1111/j.1365-2141.2000.02392.x
36. Moulas A, Challa A, Chaliasos N, Lapatsanis PD (1997) Vitamin D metabolites (25-hydroxyvitamin D, 24,25-dihydroxyvitamin D and 1,25-dihydroxyvitamin D) and osteocalcin in beta-thalassaemia. Acta Paediatr 86(6):594–599
37. Napoli N, Carmina E, Bucchieri S, Sferrazza C, Rini GB, Di Fede G (2006) Low serum levels of 25-hydroxy vitamin D in adults affected by thalassemia major or intermedia. Bone 38(6):888–892. doi:10.1016/j.bone.2005.11.018
38. Wood JC, Claster S, Carson S, Menteer JD, Hofstra T, Khanna R, Coates T (2008) Vitamin D deficiency, cardiac iron and cardiac function in thalassaemia major. Br J Haematol 141(6):891–894. doi:10.1111/j.1365-2141.2008.07135.x
39. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357(3):266–281. doi:10.1056/NEJMra070553
40. Frisk P, Arvidson J, Ljunggren O, Gustafsson J (2012) Decreased bone mineral density in young adults treated with SCT in childhood: the role of 25-hydroxyvitamin D. Bone Marrow Transplant 47(5):657–662. doi:10.1038/bmt.2011.147
41. Nakamura K, Ueno K, Nishiwaki T, Okuda Y, Saito T, Tsuchiya Y, Yamamoto M (2005) Nutrition, mild hyperparathyroidism, and bone mineral density in young Japanese women. Am J Clin Nutr 82(5):1127–1133, doi:82/5/1127 [pii]
42. Angelopoulos NG, Goula A, Rombopoulos G, Kaltzidou V, Katounda E, Kaltsas D, Tolis G (2006) Hypoparathyroidism in transfusion-dependent patients with beta-thalassemia. J Bone Miner Metab 24(2):138–145. doi:10.1007/s00774-005-0660-1
43. Laway BA, Goswami R, Singh N, Gupta N, Seith A (2006) Pattern of bone mineral density in patients with sporadic idiopathic hypoparathyroidism. Clin Endocrinol (Oxf) 64(4):405–409. doi:10.1111/j.1365-2265.2006.02479.x